前列腺放疗人群中基于治疗计划CT与BladderScan® BVI 6100超声设备的膀胱体积比较
研究比较190例前列腺放疗患者治疗计划CT勾画的膀胱体积与BladderScan® BVI 6100手持超声设备测量的膀胱体积,发现两者呈强正相关(BVImean r=0.825,BVImax r=0.830),BVImean和BVImax平均分别低估膀胱体积44.8±88.2 ml和32.9±87.5 ml;BVI 6100可为前列腺放疗患者监测膀胱体积提供可接受的指示。
要点
- BVI 6100测量值与CT勾画膀胱体积呈强正相关(BVImean r=0.825,BVImax r=0.830)。
- BVImean和BVImax均低估膀胱体积,平均差异分别为44.8±88.2 ml和32.9±87.5 ml。
- BVI 6100可为前列腺放疗患者监测膀胱体积提供可接受的指示。
核心结论
- BladderScan® BVI 6100可为前列腺放疗患者监测膀胱体积提供可接受的指示。
- BVI 6100提供了一种便捷且无辐射的膀胱体积指示方法,适用于前列腺放疗患者。
研究设计与样本
- 研究比较前列腺放疗患者基于治疗计划CT勾画的膀胱体积与BladderScan® BVI 6100超声设备测量的膀胱体积。
- 在治疗计划CT前立即使用BVI设备对前列腺放疗患者进行三次膀胱体积测量(n=190)。
- 记录CT勾画的膀胱体积,并取三次BVI读数的均值(BVImean)和最大值(BVImax)进行比较分析。
诊断标准与关键数值
- BVI与CT勾画膀胱体积呈强正相关:BVImean r=0.825,BVImax r=0.830。
- BVImean和BVImax均低估膀胱体积,平均差异(±标准差)分别为44.8±88.2 ml和32.9±87.5 ml。
局限性
- BVImean和BVImax均低估膀胱体积,平均差异分别为44.8±88.2 ml和32.9±87.5 ml。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE:: The aim of this study is to investigate if a handheld ultrasound device (BladderScan® BVI 6100) can accurately measure bladder volumes in prostate radiotherapy (RT) patients.
METHODS:: A comparison was made of contoured bladder volumes based on treatment planning CT (TPCT) and BladderScan® BVI 6100 ultrasound device in a large prostate RT population. Three bladder volume (BV) measurements were taken using the bladder volume instrument (BVI) device on prostate RT patients immediately prior to TPCT (n = 190). The CT delineation bladder volumes were also recorded. The mean of the three BVI readings (BVImean) and the maximum (BVImax) of the readings were considered for a comparative analysis.
RESULTS:: There was a strong positive correlation between the BVI and CT delineated bladder volumes (BVImean r = 0.825; BVImax r = 0.830). The mean difference [± standard deviation (SD)] was an underestimation of BV for both BVImean and BVImax (44.8 ± 88.2 ml and 32.9 ± 87.5 ml, respectively).
CONCLUSION:: This is the largest study to date (n = 190), assessing the accuracy of the BladderScan® BVI 6100 in the prostate RT population. The BVI 6100 provides an acceptable indication of BV for use in prostate RT patients for the purposes of monitoring BV.
ADVANCES IN KNOWLEDGE:: The BladderScan® BVI 6100 provides a convenient and non-irradiating method of indicating BV for use in prostate RT patients.
引用
- Mullaney L, O'Shea E, Dunne MT, et al. A comparison of bladder volumes based on treatment planning CT and BladderScan® BVI 6100 ultrasound device in a prostate radiation therapy population. Br J Radiol. 2018. PMID: 29888971. doi:10.1259/bjr.20180160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。